nodes	percent_of_prediction	percent_of_DWPC	metapath
Lurasidone—HTR7—myenteric nerve plexus—colon cancer	0.0717	0.212	CbGeAlD
Lurasidone—HTR7—vein—colon cancer	0.0462	0.137	CbGeAlD
Lurasidone—HTR2A—myenteric nerve plexus—colon cancer	0.0447	0.133	CbGeAlD
Lurasidone—HTR2A—vein—colon cancer	0.0288	0.0854	CbGeAlD
Lurasidone—HTR7—endothelium—colon cancer	0.0159	0.0471	CbGeAlD
Lurasidone—HTR7—blood vessel—colon cancer	0.0147	0.0435	CbGeAlD
Lurasidone—HTR2A—endothelium—colon cancer	0.00991	0.0294	CbGeAlD
Lurasidone—HTR2A—blood vessel—colon cancer	0.00914	0.0271	CbGeAlD
Lurasidone—HTR7—epithelium—colon cancer	0.00713	0.0211	CbGeAlD
Lurasidone—HTR1A—renal system—colon cancer	0.00692	0.0205	CbGeAlD
Lurasidone—HTR7—smooth muscle tissue—colon cancer	0.00687	0.0204	CbGeAlD
Lurasidone—HTR7—renal system—colon cancer	0.00662	0.0196	CbGeAlD
Lurasidone—ADRA2C—renal system—colon cancer	0.00608	0.018	CbGeAlD
Lurasidone—HTR2A—embryo—colon cancer	0.00545	0.0162	CbGeAlD
Lurasidone—HTR7—digestive system—colon cancer	0.00543	0.0161	CbGeAlD
Lurasidone—HTR2A—epithelium—colon cancer	0.00445	0.0132	CbGeAlD
Lurasidone—ADRA2C—vagina—colon cancer	0.0044	0.0131	CbGeAlD
Lurasidone—HTR2A—smooth muscle tissue—colon cancer	0.00429	0.0127	CbGeAlD
Lurasidone—HTR2A—renal system—colon cancer	0.00413	0.0122	CbGeAlD
Lurasidone—HTR7—liver—colon cancer	0.00404	0.012	CbGeAlD
Lurasidone—Dysarthria—Capecitabine—colon cancer	0.00386	0.00582	CcSEcCtD
Lurasidone—CYP3A4—renal system—colon cancer	0.00382	0.0113	CbGeAlD
Lurasidone—Osteoarthritis—Fluorouracil—colon cancer	0.00379	0.00572	CcSEcCtD
Lurasidone—Gait disturbance—Capecitabine—colon cancer	0.00374	0.00564	CcSEcCtD
Lurasidone—ADRA2C—liver—colon cancer	0.00372	0.011	CbGeAlD
Lurasidone—Blood creatinine increased—Irinotecan—colon cancer	0.00371	0.0056	CcSEcCtD
Lurasidone—Neck pain—Capecitabine—colon cancer	0.00369	0.00557	CcSEcCtD
Lurasidone—Pulmonary embolism—Capecitabine—colon cancer	0.00365	0.00551	CcSEcCtD
Lurasidone—Blood pressure increased—Capecitabine—colon cancer	0.00365	0.00551	CcSEcCtD
Lurasidone—Orthostatic hypotension—Irinotecan—colon cancer	0.00362	0.00545	CcSEcCtD
Lurasidone—ADRA2A—vagina—colon cancer	0.00351	0.0104	CbGeAlD
Lurasidone—Nasopharyngitis—Fluorouracil—colon cancer	0.00339	0.00511	CcSEcCtD
Lurasidone—HTR2A—digestive system—colon cancer	0.00338	0.01	CbGeAlD
Lurasidone—Angina pectoris—Irinotecan—colon cancer	0.00333	0.00503	CcSEcCtD
Lurasidone—Neutropenia—Vincristine—colon cancer	0.00328	0.00496	CcSEcCtD
Lurasidone—Dysuria—Vincristine—colon cancer	0.00328	0.00496	CcSEcCtD
Lurasidone—Dysphagia—Fluorouracil—colon cancer	0.00328	0.00494	CcSEcCtD
Lurasidone—Eosinophilia—Fluorouracil—colon cancer	0.00324	0.00489	CcSEcCtD
Lurasidone—Erectile dysfunction—Vincristine—colon cancer	0.00324	0.00488	CcSEcCtD
Lurasidone—Neutropenia—Irinotecan—colon cancer	0.0032	0.00483	CcSEcCtD
Lurasidone—Angina pectoris—Fluorouracil—colon cancer	0.00319	0.00482	CcSEcCtD
Lurasidone—CYP3A4—digestive system—colon cancer	0.00313	0.00929	CbGeAlD
Lurasidone—Sleep disorder—Capecitabine—colon cancer	0.00306	0.00462	CcSEcCtD
Lurasidone—Diabetes mellitus—Capecitabine—colon cancer	0.00305	0.0046	CcSEcCtD
Lurasidone—Musculoskeletal stiffness—Methotrexate—colon cancer	0.00303	0.00457	CcSEcCtD
Lurasidone—Renal failure—Irinotecan—colon cancer	0.003	0.00452	CcSEcCtD
Lurasidone—HTR2A—vagina—colon cancer	0.00299	0.00886	CbGeAlD
Lurasidone—Infestation—Fluorouracil—colon cancer	0.00292	0.00441	CcSEcCtD
Lurasidone—Infestation NOS—Fluorouracil—colon cancer	0.00292	0.00441	CcSEcCtD
Lurasidone—Dysarthria—Methotrexate—colon cancer	0.00287	0.00433	CcSEcCtD
Lurasidone—ADRA2C—lymph node—colon cancer	0.00285	0.00845	CbGeAlD
Lurasidone—Urinary tract infection—Fluorouracil—colon cancer	0.00284	0.00428	CcSEcCtD
Lurasidone—Hot flush—Capecitabine—colon cancer	0.00283	0.00427	CcSEcCtD
Lurasidone—Increased appetite—Capecitabine—colon cancer	0.00282	0.00425	CcSEcCtD
Lurasidone—Menopausal symptoms—Capecitabine—colon cancer	0.00281	0.00424	CcSEcCtD
Lurasidone—Bradycardia—Irinotecan—colon cancer	0.00279	0.00421	CcSEcCtD
Lurasidone—Urinary tract disorder—Vincristine—colon cancer	0.00278	0.00419	CcSEcCtD
Lurasidone—Connective tissue disorder—Vincristine—colon cancer	0.00276	0.00417	CcSEcCtD
Lurasidone—Urethral disorder—Vincristine—colon cancer	0.00276	0.00416	CcSEcCtD
Lurasidone—Agranulocytosis—Fluorouracil—colon cancer	0.00273	0.00411	CcSEcCtD
Lurasidone—Pulmonary embolism—Methotrexate—colon cancer	0.00272	0.0041	CcSEcCtD
Lurasidone—Cerebrovascular accident—Capecitabine—colon cancer	0.0027	0.00408	CcSEcCtD
Lurasidone—Lethargy—Capecitabine—colon cancer	0.0027	0.00408	CcSEcCtD
Lurasidone—Connective tissue disorder—Irinotecan—colon cancer	0.00269	0.00406	CcSEcCtD
Lurasidone—Osteoarthritis—Capecitabine—colon cancer	0.00265	0.004	CcSEcCtD
Lurasidone—Cardiac disorder—Vincristine—colon cancer	0.00261	0.00394	CcSEcCtD
Lurasidone—Angiopathy—Vincristine—colon cancer	0.00255	0.00385	CcSEcCtD
Lurasidone—Cardiac disorder—Irinotecan—colon cancer	0.00254	0.00383	CcSEcCtD
Lurasidone—HTR2A—liver—colon cancer	0.00252	0.00748	CbGeAlD
Lurasidone—Angiopathy—Irinotecan—colon cancer	0.00248	0.00375	CcSEcCtD
Lurasidone—Blood creatinine increased—Capecitabine—colon cancer	0.00248	0.00374	CcSEcCtD
Lurasidone—Mental disorder—Vincristine—colon cancer	0.00246	0.00372	CcSEcCtD
Lurasidone—Arrhythmia—Irinotecan—colon cancer	0.00245	0.00369	CcSEcCtD
Lurasidone—Orthostatic hypotension—Capecitabine—colon cancer	0.00242	0.00365	CcSEcCtD
Lurasidone—Abdominal pain upper—Capecitabine—colon cancer	0.00242	0.00365	CcSEcCtD
Lurasidone—Breast disorder—Capecitabine—colon cancer	0.00239	0.00361	CcSEcCtD
Lurasidone—Nasopharyngitis—Capecitabine—colon cancer	0.00237	0.00357	CcSEcCtD
Lurasidone—Back pain—Vincristine—colon cancer	0.00237	0.00357	CcSEcCtD
Lurasidone—Flatulence—Irinotecan—colon cancer	0.00235	0.00354	CcSEcCtD
Lurasidone—Gastritis—Capecitabine—colon cancer	0.00234	0.00354	CcSEcCtD
Lurasidone—Arrhythmia—Fluorouracil—colon cancer	0.00234	0.00354	CcSEcCtD
Lurasidone—Alanine aminotransferase increased—Capecitabine—colon cancer	0.00234	0.00353	CcSEcCtD
Lurasidone—CYP3A4—liver—colon cancer	0.00233	0.00692	CbGeAlD
Lurasidone—Back pain—Irinotecan—colon cancer	0.00231	0.00348	CcSEcCtD
Lurasidone—Muscle spasms—Irinotecan—colon cancer	0.00229	0.00346	CcSEcCtD
Lurasidone—Dysphagia—Capecitabine—colon cancer	0.00229	0.00345	CcSEcCtD
Lurasidone—Influenza—Capecitabine—colon cancer	0.00229	0.00345	CcSEcCtD
Lurasidone—ADRA2A—lymph node—colon cancer	0.00227	0.00674	CbGeAlD
Lurasidone—Diabetes mellitus—Methotrexate—colon cancer	0.00227	0.00342	CcSEcCtD
Lurasidone—Anaemia—Vincristine—colon cancer	0.00226	0.00341	CcSEcCtD
Lurasidone—Agitation—Vincristine—colon cancer	0.00225	0.00339	CcSEcCtD
Lurasidone—Angina pectoris—Capecitabine—colon cancer	0.00223	0.00337	CcSEcCtD
Lurasidone—Anaemia—Irinotecan—colon cancer	0.0022	0.00332	CcSEcCtD
Lurasidone—Vertigo—Vincristine—colon cancer	0.0022	0.00332	CcSEcCtD
Lurasidone—Abdominal discomfort—Capecitabine—colon cancer	0.00219	0.00331	CcSEcCtD
Lurasidone—Leukopenia—Vincristine—colon cancer	0.00219	0.00331	CcSEcCtD
Lurasidone—Vision blurred—Fluorouracil—colon cancer	0.00215	0.00325	CcSEcCtD
Lurasidone—Malaise—Irinotecan—colon cancer	0.00215	0.00324	CcSEcCtD
Lurasidone—Vertigo—Irinotecan—colon cancer	0.00214	0.00323	CcSEcCtD
Lurasidone—Neutropenia—Capecitabine—colon cancer	0.00214	0.00323	CcSEcCtD
Lurasidone—Dysuria—Capecitabine—colon cancer	0.00214	0.00323	CcSEcCtD
Lurasidone—Syncope—Irinotecan—colon cancer	0.00214	0.00323	CcSEcCtD
Lurasidone—Leukopenia—Irinotecan—colon cancer	0.00213	0.00322	CcSEcCtD
Lurasidone—Convulsion—Vincristine—colon cancer	0.00212	0.0032	CcSEcCtD
Lurasidone—Hypertension—Vincristine—colon cancer	0.00211	0.00319	CcSEcCtD
Lurasidone—Anaemia—Fluorouracil—colon cancer	0.00211	0.00318	CcSEcCtD
Lurasidone—Loss of consciousness—Irinotecan—colon cancer	0.0021	0.00316	CcSEcCtD
Lurasidone—Myalgia—Vincristine—colon cancer	0.00208	0.00314	CcSEcCtD
Lurasidone—Weight increased—Capecitabine—colon cancer	0.00208	0.00314	CcSEcCtD
Lurasidone—Hyperglycaemia—Capecitabine—colon cancer	0.00207	0.00312	CcSEcCtD
Lurasidone—Hypertension—Irinotecan—colon cancer	0.00206	0.00311	CcSEcCtD
Lurasidone—Leukopenia—Fluorouracil—colon cancer	0.00204	0.00308	CcSEcCtD
Lurasidone—Infestation—Capecitabine—colon cancer	0.00204	0.00308	CcSEcCtD
Lurasidone—Infestation NOS—Capecitabine—colon cancer	0.00204	0.00308	CcSEcCtD
Lurasidone—Cerebrovascular accident—Methotrexate—colon cancer	0.00201	0.00304	CcSEcCtD
Lurasidone—Lethargy—Methotrexate—colon cancer	0.00201	0.00304	CcSEcCtD
Lurasidone—Renal failure—Capecitabine—colon cancer	0.00201	0.00303	CcSEcCtD
Lurasidone—Infection—Vincristine—colon cancer	0.00198	0.00299	CcSEcCtD
Lurasidone—Urinary tract infection—Capecitabine—colon cancer	0.00198	0.00299	CcSEcCtD
Lurasidone—Convulsion—Fluorouracil—colon cancer	0.00198	0.00298	CcSEcCtD
Lurasidone—Osteoarthritis—Methotrexate—colon cancer	0.00197	0.00298	CcSEcCtD
Lurasidone—Nervous system disorder—Vincristine—colon cancer	0.00196	0.00296	CcSEcCtD
Lurasidone—Myalgia—Fluorouracil—colon cancer	0.00194	0.00293	CcSEcCtD
Lurasidone—Infection—Irinotecan—colon cancer	0.00193	0.00292	CcSEcCtD
Lurasidone—Hyperhidrosis—Vincristine—colon cancer	0.00193	0.00291	CcSEcCtD
Lurasidone—Hepatobiliary disease—Capecitabine—colon cancer	0.00193	0.00291	CcSEcCtD
Lurasidone—Shock—Irinotecan—colon cancer	0.00191	0.00289	CcSEcCtD
Lurasidone—Nervous system disorder—Irinotecan—colon cancer	0.00191	0.00288	CcSEcCtD
Lurasidone—Agranulocytosis—Capecitabine—colon cancer	0.00191	0.00287	CcSEcCtD
Lurasidone—Hyperhidrosis—Irinotecan—colon cancer	0.00188	0.00284	CcSEcCtD
Lurasidone—Hypotension—Vincristine—colon cancer	0.00187	0.00282	CcSEcCtD
Lurasidone—Bradycardia—Capecitabine—colon cancer	0.00187	0.00282	CcSEcCtD
Lurasidone—Infection—Fluorouracil—colon cancer	0.00185	0.00279	CcSEcCtD
Lurasidone—Nervous system disorder—Fluorouracil—colon cancer	0.00183	0.00276	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Vincristine—colon cancer	0.00182	0.00275	CcSEcCtD
Lurasidone—Tachycardia—Fluorouracil—colon cancer	0.00182	0.00274	CcSEcCtD
Lurasidone—Hypotension—Irinotecan—colon cancer	0.00182	0.00274	CcSEcCtD
Lurasidone—Urinary tract disorder—Capecitabine—colon cancer	0.00181	0.00273	CcSEcCtD
Lurasidone—Insomnia—Vincristine—colon cancer	0.00181	0.00273	CcSEcCtD
Lurasidone—Connective tissue disorder—Capecitabine—colon cancer	0.0018	0.00272	CcSEcCtD
Lurasidone—Urethral disorder—Capecitabine—colon cancer	0.0018	0.00271	CcSEcCtD
Lurasidone—Breast disorder—Methotrexate—colon cancer	0.00178	0.00269	CcSEcCtD
Lurasidone—Insomnia—Irinotecan—colon cancer	0.00176	0.00265	CcSEcCtD
Lurasidone—Hypotension—Fluorouracil—colon cancer	0.00174	0.00263	CcSEcCtD
Lurasidone—Decreased appetite—Vincristine—colon cancer	0.00174	0.00262	CcSEcCtD
Lurasidone—Dyspnoea—Irinotecan—colon cancer	0.00173	0.00262	CcSEcCtD
Lurasidone—Somnolence—Irinotecan—colon cancer	0.00173	0.00261	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Vincristine—colon cancer	0.00172	0.0026	CcSEcCtD
Lurasidone—Fatigue—Vincristine—colon cancer	0.00172	0.0026	CcSEcCtD
Lurasidone—Eye disorder—Capecitabine—colon cancer	0.00171	0.00258	CcSEcCtD
Lurasidone—Dyspepsia—Irinotecan—colon cancer	0.00171	0.00258	CcSEcCtD
Lurasidone—Cardiac disorder—Capecitabine—colon cancer	0.0017	0.00257	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.0017	0.00256	CcSEcCtD
Lurasidone—Decreased appetite—Irinotecan—colon cancer	0.00169	0.00255	CcSEcCtD
Lurasidone—Eosinophilia—Methotrexate—colon cancer	0.00169	0.00255	CcSEcCtD
Lurasidone—Insomnia—Fluorouracil—colon cancer	0.00169	0.00254	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Irinotecan—colon cancer	0.00168	0.00253	CcSEcCtD
Lurasidone—Fatigue—Irinotecan—colon cancer	0.00168	0.00253	CcSEcCtD
Lurasidone—Angiopathy—Capecitabine—colon cancer	0.00166	0.00251	CcSEcCtD
Lurasidone—Dyspnoea—Fluorouracil—colon cancer	0.00166	0.00251	CcSEcCtD
Lurasidone—Somnolence—Fluorouracil—colon cancer	0.00166	0.0025	CcSEcCtD
Lurasidone—Dyspepsia—Fluorouracil—colon cancer	0.00164	0.00247	CcSEcCtD
Lurasidone—Arrhythmia—Capecitabine—colon cancer	0.00164	0.00247	CcSEcCtD
Lurasidone—Abdominal discomfort—Methotrexate—colon cancer	0.00163	0.00247	CcSEcCtD
Lurasidone—Gastrointestinal pain—Vincristine—colon cancer	0.00163	0.00246	CcSEcCtD
Lurasidone—Decreased appetite—Fluorouracil—colon cancer	0.00162	0.00244	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Fluorouracil—colon cancer	0.00161	0.00243	CcSEcCtD
Lurasidone—Mental disorder—Capecitabine—colon cancer	0.00161	0.00242	CcSEcCtD
Lurasidone—Malnutrition—Capecitabine—colon cancer	0.0016	0.00241	CcSEcCtD
Lurasidone—Dysuria—Methotrexate—colon cancer	0.00159	0.0024	CcSEcCtD
Lurasidone—Neutropenia—Methotrexate—colon cancer	0.00159	0.0024	CcSEcCtD
Lurasidone—Gastrointestinal pain—Irinotecan—colon cancer	0.00159	0.0024	CcSEcCtD
Lurasidone—Abdominal pain—Vincristine—colon cancer	0.00158	0.00238	CcSEcCtD
Lurasidone—Flatulence—Capecitabine—colon cancer	0.00157	0.00237	CcSEcCtD
Lurasidone—Erectile dysfunction—Methotrexate—colon cancer	0.00157	0.00237	CcSEcCtD
Lurasidone—Back pain—Capecitabine—colon cancer	0.00154	0.00233	CcSEcCtD
Lurasidone—Abdominal pain—Irinotecan—colon cancer	0.00154	0.00232	CcSEcCtD
Lurasidone—Muscle spasms—Capecitabine—colon cancer	0.00153	0.00231	CcSEcCtD
Lurasidone—Infestation—Methotrexate—colon cancer	0.00152	0.00229	CcSEcCtD
Lurasidone—Infestation NOS—Methotrexate—colon cancer	0.00152	0.00229	CcSEcCtD
Lurasidone—Vision blurred—Capecitabine—colon cancer	0.0015	0.00227	CcSEcCtD
Lurasidone—Tremor—Capecitabine—colon cancer	0.00149	0.00226	CcSEcCtD
Lurasidone—Renal failure—Methotrexate—colon cancer	0.00149	0.00225	CcSEcCtD
Lurasidone—Anaemia—Capecitabine—colon cancer	0.00147	0.00222	CcSEcCtD
Lurasidone—Malaise—Capecitabine—colon cancer	0.00144	0.00217	CcSEcCtD
Lurasidone—Hepatobiliary disease—Methotrexate—colon cancer	0.00144	0.00217	CcSEcCtD
Lurasidone—Vertigo—Capecitabine—colon cancer	0.00143	0.00216	CcSEcCtD
Lurasidone—Asthenia—Vincristine—colon cancer	0.00143	0.00216	CcSEcCtD
Lurasidone—Syncope—Capecitabine—colon cancer	0.00143	0.00216	CcSEcCtD
Lurasidone—Leukopenia—Capecitabine—colon cancer	0.00143	0.00215	CcSEcCtD
Lurasidone—Agranulocytosis—Methotrexate—colon cancer	0.00142	0.00214	CcSEcCtD
Lurasidone—Loss of consciousness—Capecitabine—colon cancer	0.0014	0.00212	CcSEcCtD
Lurasidone—Asthenia—Irinotecan—colon cancer	0.0014	0.00211	CcSEcCtD
Lurasidone—Hypertension—Capecitabine—colon cancer	0.00138	0.00208	CcSEcCtD
Lurasidone—Diarrhoea—Vincristine—colon cancer	0.00137	0.00206	CcSEcCtD
Lurasidone—Myalgia—Capecitabine—colon cancer	0.00136	0.00205	CcSEcCtD
Lurasidone—Anxiety—Capecitabine—colon cancer	0.00135	0.00204	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.00135	0.00204	CcSEcCtD
Lurasidone—Urinary tract disorder—Methotrexate—colon cancer	0.00135	0.00203	CcSEcCtD
Lurasidone—Urethral disorder—Methotrexate—colon cancer	0.00134	0.00202	CcSEcCtD
Lurasidone—Diarrhoea—Irinotecan—colon cancer	0.00133	0.00201	CcSEcCtD
Lurasidone—Dry mouth—Capecitabine—colon cancer	0.00133	0.002	CcSEcCtD
Lurasidone—Dizziness—Vincristine—colon cancer	0.00132	0.00199	CcSEcCtD
Lurasidone—Pruritus—Fluorouracil—colon cancer	0.00132	0.00199	CcSEcCtD
Lurasidone—Infection—Capecitabine—colon cancer	0.00129	0.00195	CcSEcCtD
Lurasidone—Dizziness—Irinotecan—colon cancer	0.00129	0.00194	CcSEcCtD
Lurasidone—Shock—Capecitabine—colon cancer	0.00128	0.00193	CcSEcCtD
Lurasidone—Nervous system disorder—Capecitabine—colon cancer	0.00128	0.00193	CcSEcCtD
Lurasidone—Eye disorder—Methotrexate—colon cancer	0.00127	0.00192	CcSEcCtD
Lurasidone—Diarrhoea—Fluorouracil—colon cancer	0.00127	0.00192	CcSEcCtD
Lurasidone—Tachycardia—Capecitabine—colon cancer	0.00127	0.00192	CcSEcCtD
Lurasidone—Vomiting—Vincristine—colon cancer	0.00127	0.00192	CcSEcCtD
Lurasidone—Cardiac disorder—Methotrexate—colon cancer	0.00127	0.00191	CcSEcCtD
Lurasidone—Skin disorder—Capecitabine—colon cancer	0.00126	0.00191	CcSEcCtD
Lurasidone—Rash—Vincristine—colon cancer	0.00126	0.0019	CcSEcCtD
Lurasidone—Hyperhidrosis—Capecitabine—colon cancer	0.00126	0.0019	CcSEcCtD
Lurasidone—Dermatitis—Vincristine—colon cancer	0.00126	0.0019	CcSEcCtD
Lurasidone—Angiopathy—Methotrexate—colon cancer	0.00124	0.00187	CcSEcCtD
Lurasidone—Vomiting—Irinotecan—colon cancer	0.00124	0.00187	CcSEcCtD
Lurasidone—Dizziness—Fluorouracil—colon cancer	0.00123	0.00186	CcSEcCtD
Lurasidone—Rash—Irinotecan—colon cancer	0.00123	0.00185	CcSEcCtD
Lurasidone—Dermatitis—Irinotecan—colon cancer	0.00123	0.00185	CcSEcCtD
Lurasidone—Hypotension—Capecitabine—colon cancer	0.00122	0.00184	CcSEcCtD
Lurasidone—Mental disorder—Methotrexate—colon cancer	0.0012	0.0018	CcSEcCtD
Lurasidone—Malnutrition—Methotrexate—colon cancer	0.00119	0.00179	CcSEcCtD
Lurasidone—Nausea—Vincristine—colon cancer	0.00119	0.00179	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00119	0.00179	CcSEcCtD
Lurasidone—Vomiting—Fluorouracil—colon cancer	0.00118	0.00179	CcSEcCtD
Lurasidone—Insomnia—Capecitabine—colon cancer	0.00118	0.00178	CcSEcCtD
Lurasidone—Rash—Fluorouracil—colon cancer	0.00117	0.00177	CcSEcCtD
Lurasidone—Dermatitis—Fluorouracil—colon cancer	0.00117	0.00177	CcSEcCtD
Lurasidone—Dyspnoea—Capecitabine—colon cancer	0.00116	0.00175	CcSEcCtD
Lurasidone—Nausea—Irinotecan—colon cancer	0.00116	0.00174	CcSEcCtD
Lurasidone—Back pain—Methotrexate—colon cancer	0.00115	0.00173	CcSEcCtD
Lurasidone—Dyspepsia—Capecitabine—colon cancer	0.00115	0.00173	CcSEcCtD
Lurasidone—Decreased appetite—Capecitabine—colon cancer	0.00113	0.00171	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Capecitabine—colon cancer	0.00112	0.0017	CcSEcCtD
Lurasidone—Fatigue—Capecitabine—colon cancer	0.00112	0.00169	CcSEcCtD
Lurasidone—Vision blurred—Methotrexate—colon cancer	0.00112	0.00169	CcSEcCtD
Lurasidone—Nausea—Fluorouracil—colon cancer	0.00111	0.00167	CcSEcCtD
Lurasidone—Anaemia—Methotrexate—colon cancer	0.0011	0.00166	CcSEcCtD
Lurasidone—Malaise—Methotrexate—colon cancer	0.00107	0.00162	CcSEcCtD
Lurasidone—Vertigo—Methotrexate—colon cancer	0.00107	0.00161	CcSEcCtD
Lurasidone—Gastrointestinal pain—Capecitabine—colon cancer	0.00106	0.00161	CcSEcCtD
Lurasidone—Leukopenia—Methotrexate—colon cancer	0.00106	0.0016	CcSEcCtD
Lurasidone—Abdominal pain—Capecitabine—colon cancer	0.00103	0.00155	CcSEcCtD
Lurasidone—Convulsion—Methotrexate—colon cancer	0.00103	0.00155	CcSEcCtD
Lurasidone—Myalgia—Methotrexate—colon cancer	0.00101	0.00153	CcSEcCtD
Lurasidone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.001	0.00152	CcSEcCtD
Lurasidone—Infection—Methotrexate—colon cancer	0.000963	0.00145	CcSEcCtD
Lurasidone—Nervous system disorder—Methotrexate—colon cancer	0.000951	0.00143	CcSEcCtD
Lurasidone—Skin disorder—Methotrexate—colon cancer	0.000941	0.00142	CcSEcCtD
Lurasidone—Hyperhidrosis—Methotrexate—colon cancer	0.000937	0.00141	CcSEcCtD
Lurasidone—Asthenia—Capecitabine—colon cancer	0.000934	0.00141	CcSEcCtD
Lurasidone—Pruritus—Capecitabine—colon cancer	0.000921	0.00139	CcSEcCtD
Lurasidone—Hypotension—Methotrexate—colon cancer	0.000906	0.00137	CcSEcCtD
Lurasidone—Diarrhoea—Capecitabine—colon cancer	0.000891	0.00134	CcSEcCtD
Lurasidone—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000883	0.00133	CcSEcCtD
Lurasidone—Insomnia—Methotrexate—colon cancer	0.000877	0.00132	CcSEcCtD
Lurasidone—Dyspnoea—Methotrexate—colon cancer	0.000864	0.0013	CcSEcCtD
Lurasidone—Somnolence—Methotrexate—colon cancer	0.000862	0.0013	CcSEcCtD
Lurasidone—Dizziness—Capecitabine—colon cancer	0.000861	0.0013	CcSEcCtD
Lurasidone—Dyspepsia—Methotrexate—colon cancer	0.000853	0.00129	CcSEcCtD
Lurasidone—Decreased appetite—Methotrexate—colon cancer	0.000843	0.00127	CcSEcCtD
Lurasidone—Gastrointestinal disorder—Methotrexate—colon cancer	0.000837	0.00126	CcSEcCtD
Lurasidone—Fatigue—Methotrexate—colon cancer	0.000836	0.00126	CcSEcCtD
Lurasidone—Vomiting—Capecitabine—colon cancer	0.000828	0.00125	CcSEcCtD
Lurasidone—Rash—Capecitabine—colon cancer	0.000821	0.00124	CcSEcCtD
Lurasidone—Dermatitis—Capecitabine—colon cancer	0.00082	0.00124	CcSEcCtD
Lurasidone—Gastrointestinal pain—Methotrexate—colon cancer	0.000793	0.0012	CcSEcCtD
Lurasidone—Nausea—Capecitabine—colon cancer	0.000773	0.00117	CcSEcCtD
Lurasidone—Abdominal pain—Methotrexate—colon cancer	0.000766	0.00116	CcSEcCtD
Lurasidone—Asthenia—Methotrexate—colon cancer	0.000695	0.00105	CcSEcCtD
Lurasidone—Pruritus—Methotrexate—colon cancer	0.000686	0.00103	CcSEcCtD
Lurasidone—Diarrhoea—Methotrexate—colon cancer	0.000663	0.001	CcSEcCtD
Lurasidone—Dizziness—Methotrexate—colon cancer	0.000641	0.000967	CcSEcCtD
Lurasidone—Vomiting—Methotrexate—colon cancer	0.000616	0.00093	CcSEcCtD
Lurasidone—Rash—Methotrexate—colon cancer	0.000611	0.000922	CcSEcCtD
Lurasidone—Dermatitis—Methotrexate—colon cancer	0.000611	0.000921	CcSEcCtD
Lurasidone—Nausea—Methotrexate—colon cancer	0.000576	0.000869	CcSEcCtD
